Royalty Pharma Revenue

Royalty Pharma had revenue of $609.29M USD in the quarter ending September 30, 2025, with 7.90% growth. This brings the company's revenue in the last twelve months to $2.35B, up 3.70% year-over-year. In the year 2024, Royalty Pharma had annual revenue of $2.26B, down -3.86%.

Revenue (ttm)

$2.35B

Revenue Growth

+3.70%

P/S Ratio

7.29

Revenue / Employee

n/a

Employees

n/a

Market Cap

14.59B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.26B	-90.98M	-3.86%
Dec 31, 2023	2.35B	117.34M	5.24%
Dec 31, 2022	2.24B	-52.25M	-2.28%
Dec 31, 2021	2.29B	167.11M	7.87%
Dec 31, 2020	2.12B	308.10M	16.98%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SAP SE	36.49B
Siemens Aktiengesellschaft	78.91B
Allianz SE	105.02B
Deutsche Telekom AG	121.02B
Siemens Energy AG	39.08B
Rheinmetall AG	11.00B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	62.10B
Deutsche Bank Aktiengesellschaft	29.86B

Revenue Rankings